Bone Morphogenetic Protein Use in Veterinary Orthopedics: A New Frontier
Investment Trends – Who Is Funding the BMP Revolution?
Investment in the Bone Morphogenetic Protein Market is gaining momentum. Venture capital firms, biotech investors, and government agencies are all funding BMP innovations, particularly in delivery technologies and biosimilars.
Startups focusing on novel BMP-based therapies or combination products are attracting significant seed and Series A rounds. Additionally, public funding for orthopedic regenerative medicine has been increasing as governments prioritize aging populations and healthcare efficiency.
M&A activity is also on the rise, with large medical device companies acquiring promising biotech firms to expand their product portfolios.
1 View